Research Report and Overview on Biologics Contract Manufacturing Market, 2017-2027

Biologics Contract Manufacturing Market Expected to Dominate Worldwide by 2027 January 2017

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities    

Customized Research Syndicated Research Investment Research

Social Media Research

Customized Research Syndicated Research Investment Research Social Media Research

Sector Coverage    

Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

   

Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

2

Research Methodology (1/2) Systematic Research Approach 1 Market profiling

2 Formulating discussion guide

3 Developing list of respondents

4

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts

Data collection

PMR conducts interviews with industry experts, industry players, distributors and retailers

Data validation

Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data

5 6

Data analysis

Insights

7

Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF)

Data Collection

   

Research & Intelligence

Data Filter & Analysis

Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain

Actionable Insights

A Primary Research

     

B SOLUTION     

Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments

Primary Research #    

Linkedin Zoominfo Salesforce Avention

Business Solution

Desk Research

C

Key industry experts Channel study Developments Market dynamics Products Conclusions

Company Analysis

Secondary Research #    

Company websites Company annual reports White papers Financial reports

Paid Publications#    

Factiva GBI Genios Meltwater

# includes sources of databases

3

Biologics Contract Manufacturing Market Biologics are genetically engineered proteins which originate from human genes. These drugs target the specific parts of the immune system. Biologics are entirely different from chemically synthesized drugs. There is wide range of biologics products include vaccines, blood components, allergenic, somatic cells, gene therapy and recombinant therapeutic proteins. Biologics are constituted as nucleic acids or proteins or may be cells and tissue from living entities. Biologics are isolated from different sources such as animal, human or microbes by using different biotechnological methods. Biologics are a complex mixture, and it is heat sensitive product and highly susceptible to microbial contamination. Therefore manufacturing of biologics needs very aseptic environment and skilled professional. Hence, the demand for biologic contract manufacturing has shown subsequent growth. The pharmaceutical companies are signing an agreement with CMOâ&#x20AC;&#x2122;s for the manufacturing of biologics. Biologics Contract Manufacturing Market: Drivers and Restraints The factors driving the growth of biologics contract manufacturing are growing number of drug development by traditional pharmaceutical companies and the entrance of various small manufacturers in the pharmaceutical market. Increasing rate of drug approval by FDA and number drugs in the pipeline has also boosted the growth of biologic contract manufacturing market. Increase in generic drugs competition and rise in patent expiry has also propelled the growth of biologics contract manufacturing market. Increasing geriatric population and increasing the prevalence of diseases such as cancer are driving the growth of biologic contract manufacturing market. Production of biologics requires highly skilled professional and aseptic environment which will restrain the growth of this market. Beside that production of biologics are very complex and costly method which can again hamper the growth of this ÂŠ2015 Future Market Insights, All Rights Reserved

4

Biologics Contract Manufacturing Market market. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2679 Biologics Contract Manufacturing Market: Segmentation Based on product type biologics contract manufacturing market is segmented into following  Antisense  Cell Therapy  Gene Therapy  Growth Factors  Interferon’s Based on indication biologics contract manufacturing market is segmented into following

5

Biologics Contract Manufacturing Market  Autoimmune Disorders  Blood Disorders  Cancer  Cardiovascular Diseases  Digestive Disorder Based on geography biologics contract manufacturing market is segmented into following  North America  Latin America  Western Europe Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2679

6

Biologics Contract Manufacturing Market Biologics Contract Manufacturing Market: Overview Biologics contract manufacturing is expected to show significant growth over the forecast period. Biologics cover around 10-15% of revenue from overall revenue generated by leading pharmaceutical companies. Biologics contract manufacturing market is expected to show double growth in every five years. This market is growing because of traditional pharmaceutical companies are unable for meet the need required for the production of biologics, besides that they are also the lack of skilled professional. Biologic contract manufacturing market can be classified by product type and indication. On the basis on product type biologic contract manufacturing market is classified as antisense, gene therapy, cell therapy, growth factors, interferon’s, monoclonal antibodies, recombinant hormones, RNA interference, vaccines and others. From all product type monoclonal antibodies is expected to dominate the biologic contract manufacturing market. Biologics Contract Manufacturing Market: Regional Overview Region-wise contract manufacturing market is classified as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America is expected to dominate the biologics contract manufacturing due to rise in FDA approval in last decade. Western Europe and Asia-Pacific then follow this market. Western Europe is projected to show subsequent growth due to the high availability of skilled professional for the production of biologics. AsiaPacific region is expected to show the fastest growth over the forecast period owing to rise in the number of CMO’s. ©2015 Future Market Insights, All Rights Reserved

7

Biologics Contract Manufacturing Market Browse Full Report@ http://www.futuremarketinsights.com/reports/biologics-contract-manufacturing-market Biologics Contract Manufacturing Market: Key Players Some of the key players in biologics contract manufacturing market are Boehringer Ingelheim, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Rentschler Biotechnologie GmbH, Celonic AG, AutekBio Co. Ltd., WuXiAppTec, Kemwell Biopharma, Shasun Pharma, Intas Pharmaceuticals, Syngene, Piramal Pharma Solutions, AAIPharma Services, Alpax Pharmaceuticals, Cantab Biopharmaceuticals Ltd, 3P Biopharmaceuticals, and BIBITEC GmbH.

Click here to Order a free sample

8

To know more about us, please visit our website:

www.futuremarketinsights.com For sales queries or new topics email us on:

sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Thank You Future Market Insights Global & Consulting Private Limited (FMI)

9

Turn static files into dynamic content formats.

Create a flipbook